³Ô¹ÏÍøÕ¾

Latest therapeutics News

Amplia enters into preclinical collaboration with Korean drug screening company
Power Of Human Milk For Infant Health
World Diabetes Day: New GP guideline adds focus on remission, sleep, and weight management interventions
‘Sleepy cannabis’: first objective study to show cannabinol increases sleep
Over 36 Mkr from the Swedish Research Council to MTC researchers
Enzyme engineering has the potential to drive green, more efficient drug manufacturing
Helping hand for WA’s health and medical life sciences sector
Potential drugs for cancer treatment may help tackle tuberculosis
UQ Researchers Support Cardiovascular Research
Researcher Awarded Heart Foundation Fellowship
ADx NeuroSciences and Alamar Biosciences Announce Partnership to Provide Customized Blood-Based Biomarker Assay Solutions to Accelerate Biopharma Clinical Development
Heatwaves and an aging population increase the risk of severe electrolyte imbalances
$6 Million Boost For Industry Research Projects
Seaport Therapeutics secures US$225 Series B funding to develop neuropsychiatric medicines using Monash University prodrug technology
Chimeric secures commitments for placement to progress development of CHM CDH17
Hundreds Of Illegal Vapes Seized Across Greater Darwin
University partners with new national research hub which is revolutionising healthcare
Active Substance Prevents MRNA Degradation
Origin Of Deadly Ovarian Cancer Identified
Athos Announces Positive Topline Phase 1 Data for its AI-Generated, Novel, Oral G9A Inhibitor ATH-063, Demonstrating Selective Expansion and Activation of Potent…
New WHO report presents progress in G7 countries in tackling antibiotic pipeline crisis
New antibody-like molecule which could be used in therapy to prevent infection from multiple forms of malaria
Bondi Junction response must include increased funding and support for severe mental illness: New poll
Chimeric says cancer patient achieves complete response in CHM CORE-NK trial
MicroRNA is the Nobel-winning master regulator of the genome – researchers are learning to treat disease by harnessing how it controls genes
New Healthcare Agreement Translates Into Global Good
Crown Bioscience Expands Singapore Facility with Advanced Oncology Models and Imaging Capabilities
Percheron Therapeutics updates on Avicursen primate toxicology study
Nanoscope Therapeutics Licenses Optogenetic Technology
Multiple surgeries could contribute to cognitive decline in older people
INBRAIN Neuroelectronics Announces World’s First Human Graphene-Based Brain Computer Interface Procedure
Argenica reports positive results in IND-enabling trials
Chimeric announces new collaboration with Achieve Clinics
Center for NextGen Therapeutics helps match researchers to molecules
Accelerating Pioneering Inflammatory Diseases Research
Antiviral-resistant SARS-CoV-2 variants can emerge in immunocompromised people
Organon to Acquire Dermavant including its Innovative Dermatologic Therapy, VTAMA® (tapinarof) Cream, 1%
Ripple Therapeutics Announces Collaboration and Option-to-License Agreement with AbbVie to Develop Next-Generation Therapies for Glaucoma Management
Remembering Biotech Trailblazer Leon Serry AM
Study reveals how COVID-19 infection can cause or worsen diabetes
Top Perth Leukaemia Researcher Wins Prestigious Award
Cumming Global Centre for Pandemic Therapeutics and University of Bonn announce AUD$54 million partnership
ITM Obtains Exclusive Worldwide License from Debiopharm for CA IX-Targeted Peptide-based Radiopharmaceutical Programs Targeting Solid Tumors
PolyU and University of Waterloo partner to establish the Research Centre for Nanoscience and Nanotechnology for advanced applications
World-first Florey research aims to rapidly and accurately screen drugs to treat motor neurone disease
MRM Health Appoints Grégoire Franoux as Chief Business Officer and Adds Ron Robison to its Board of Directors
Construction starts on RNA research and manufacturing facility for NSW
Investing In Life Saving Technology